Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial by Campion, SL, Brenna, E, Thomson, E, Fischer, W, Ladell, K, McLaren, JE, Price, DA, Frahm, N, McElrath, JM, Cohen, KW, Maenza, JR, Walsh, SR, Baden, LR, Haynes, BF, Korber, B, Borrow, P, McMichael, AJ

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency by Lahman, MC, Schmitt, TM, Paulson, KG, Vigneron, N, Buenrostro, D, Wagener, FD, Voillet, V, Martin, L, Gottardo, R, Bielas, J, McElrath, JM, Stirewalt, DL, Pogosova-Agadjanyan, EL, Yeung, CC, Pierce, RH, Egan, DN, Bar, M, Hendrie, PC, Kinsella, S, Vakil, A, Butler, J, Chaffee, M, Linton, J, McAfee, MS, Hunter, DS, Bleakley, M, Rongvaux, A, Van den Eynde, BJ, Chapuis, AG, Greenberg, PD